✦ LIBER ✦

Moderate dose capecitabine in older patients with metastatic breast cancer: A standard option for first line treatment?

✍ Scribed by A.A. Kotsori; J.L. Noble; S. Ashley; S. Johnston; I.E. Smith

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line therapy with moderate dose ca

✍ M. Kaufmann; N. Maass; S.D. Costa; A. Schneeweiß; S. Loibl; M.W. Sütterlin; I. S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 555 KB

NICE guidance on bevacizumab in combinat

✍ Nwamaka Umeweni; Kay Nolan; Helen Knight; Peter Clark 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 50 KB

Capecitabine and bevacizumab as first-li

✍ Feliu, J; Safont, M J; Salud, A; Losa, F; García-Girón, C; Bosch, C; Escudero, P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB

Bevacizumab in combination with biweekly

✍ García-Alfonso, P; Muñoz-Martin, A J; Alvarez-Suarez, S; Jerez-Gilarranz, Y; Rie 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 243 KB

Activity and safety of vinorelbine and c

✍ R. Palumbo; A. Bernardo; M. Strada; C. Teragni; G. Poggi; M. Frascaroli; A. Amat 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Phase II Multicenter Trial of Albumin-Bo

✍ Lee S. Schwartzberg; Francis P. Arena; David M. Mintzer; Amanda L. Epperson; Mar 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 391 KB